Data Integration Strategies in Drug
& Diagnostic Development
Sign Up Today
See how the leaders in biotech and pharma are discovering and developing new drugs with clever data integration strategies.
In this Symposium
Dr Stephanie Yaung
As a Senior Manager in Global Medical and Scientific Affairs at Roche Sequencing Solutions, Dr. Yaung generates and communicates clinical evidence supporting sequencing assays and informatics solutions.
Prof. Richard Kennedy
Almac Diagnostic Services
Professor Richard Kennedy is Global VP of Biomarker Development, Medical Director and CLIA compliant Laboratory Director at Almac Diagnostic Services. He is responsible for the application of the company’s technology into medical practice.
Dr Munisha Smalley
Dr Smalley is a Senior Scientist in Translational Sciences at TCR² Therapeutics, she is responsible for integrating data to generate translational insights into the two current clinical trials underway at TCR².
Dr Matt Alderdice
Matt joined Sonrai Analytics as Head of Data Science in 2019. His current work involves developing novel methods of stratifying cancer patients to improve outcomes using AI and machine learning.
Sonrai Analytics' expert team of software engineers and data scientists use cutting-edge technology to enable discovery within precision healthcare.
Our ability to cleanse, manage and analyise integrated data makes us uniquely positioned to support biotech, pharma and CRO's in the search for new drug development, better research and to grow rapidly.